North American Right to ONZETRA XSAIL Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

North American Right to ONZETRA XSAIL General Information

Description

Rights to Onzetra Xsail intranasal dry powder sumatriptan.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 30 Enterprise
  • Suite 400
  • Aliso Viejo, CA 92656
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • 30 Enterprise
  • Suite 400
  • Aliso Viejo, CA 92656
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

North American Right to ONZETRA XSAIL Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore North American Right to ONZETRA XSAIL‘s full profile, request access.

Request a free trial

North American Right to ONZETRA XSAIL Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore North American Right to ONZETRA XSAIL‘s full profile, request access.

Request a free trial

North American Right to ONZETRA XSAIL FAQs

  • Where is North American Right to ONZETRA XSAIL headquartered?

    North American Right to ONZETRA XSAIL is headquartered in Aliso Viejo, CA.

  • What industry is North American Right to ONZETRA XSAIL in?

    North American Right to ONZETRA XSAIL’s primary industry is Buildings and Property.

  • Is North American Right to ONZETRA XSAIL a private or public company?

    North American Right to ONZETRA XSAIL is a Private company.

  • What is North American Right to ONZETRA XSAIL’s current revenue?

    The current revenue for North American Right to ONZETRA XSAIL is .

  • Who are North American Right to ONZETRA XSAIL’s investors?

    Avanir Pharmaceuticals has invested in North American Right to ONZETRA XSAIL.

  • When was North American Right to ONZETRA XSAIL acquired?

    North American Right to ONZETRA XSAIL was acquired on 26-Sep-2019.

  • Who acquired North American Right to ONZETRA XSAIL?

    North American Right to ONZETRA XSAIL was acquired by Pernix Therapeutical Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process